Billerica, MA, United States of America

Dawn Mattoon

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Quanterix Corporation. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dawn Mattoon: Innovator in Antibody Testing

Introduction

Dawn Mattoon is a prominent inventor based in Billerica, MA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of antibody testing. Her innovative work has the potential to enhance the detection of infectious diseases.

Latest Patents

Dawn Mattoon holds a patent for a quantitative antibody test. This patent relates to methods and compositions, including kits, for quantitatively detecting an antibody of a subject to an infectious organism. Specifically, it provides methods for detecting a human antibody to SARS-CoV-2 polypeptide or S (spike) polypeptide. The applications of her patent are crucial for improving diagnostic capabilities in the medical field.

Career Highlights

Dawn Mattoon has established herself as a key figure in her field through her innovative research and development efforts. Her work at Quanterix Corporation has been instrumental in advancing technologies related to antibody detection. With her expertise, she continues to contribute to the scientific community and the development of effective diagnostic tools.

Collaborations

Dawn collaborates with talented individuals such as Andrew Ball and Lei Chang. These partnerships enhance her research and contribute to the success of her projects.

Conclusion

Dawn Mattoon is a remarkable inventor whose work in antibody testing is paving the way for advancements in medical diagnostics. Her contributions are vital for the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…